Cardona-Loya Octavio MD - 91911 Chula Vista, CA

Business Name: Cardona-Loya Octavio MD
Categorized In: Doctors
Address: 750 Medical Center Court # 4, Chula Vista, CA 91911
Phone Number: (619) 421-8360
Contact Person: Octavio Cardona-Loya
NAICS Code: 6211110
SIC Code: 8011
Business Type: B2C (Business to Consumer)
Founding Year: 1981
Employee #: 1 to 4
Location Type: Single Location
Annual Revenue ($): $500.000 to $999.999
Share This Business:
Similar Businesses: Shah Meera T MD - Chula Vista, CA 91911
Renslow Scott D MD - Chula Vista, CA 91911
Laue Edward A MD - Chula Vista, CA 91911
Anguaino Francisco E MD - Chula Vista, CA 91911
Children's Primary Care - Chula Vista, CA 91911
Reynoso Teresa MD - Chula Vista, CA 91911
Jockin Yvette M MD - Chula Vista, CA 91911
Kho Peter MD - Chula Vista, CA 91911
Aftandelians Rouben MD - Chula Vista, CA 91911
Arthur Meza Md - Chula Vista, CA 91911
Franey Bridgette B MD - Chula Vista, CA 91911
Tessier Adla MD - Chula Vista, CA 91911
Sanchez Ruben E MD - Chula Vista, CA 91911
Hernandez Francisco MD - Chula Vista, CA 91911
Sharp Centers For Rehab - Chula Vista, CA 91911
Song S Y Thomas MD - Chula Vista, CA 91911
Robles-Goche Ruth M MD - Chula Vista, CA 91911
Curtis Elaine L MD - Chula Vista, CA 91911
Sanzone Ronald MD - Chula Vista, CA 91911
Rensink Michael J MD - Chula Vista, CA 91911

Cardona-Loya Octavio MD provides professional Doctors from its single location at the coordinates 32.6189,-117.0248.

The company offers B2C variables under the SIC code 8011 and NAICS code 6211110, while making an annual revenue of $500.000 to $999.999 and hiring a total of 1 to 4 employees.

Founded in 1981, the company can now be visited at 750 Medical Center Court # 4, Chula Vista, California 91911 or contacted through representative Octavio Cardona-Loya at (619) 421-8360.

For frequently asked questions and further inquiries about professional Doctors, get to know more about Cardona-Loya Octavio MD through its company website at . Engage with this business on its social media platforms through on Twitter and on Facebook.